Cornercap Investment Counsel’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-24,396
Closed -$1.16M 639
2023
Q4
$1.16M Sell
24,396
-23
-0.1% -$967 0.19% 172
2023
Q3
$1.08M Sell
24,419
-470
-2% -$21.8K 0.2% 143
2023
Q2
$1.19M Sell
24,889
-12,118
-33% -$546K 0.21% 135
2023
Q1
$1.46M Buy
37,007
+217
+0.6% +$7.89K 0.26% 94
2022
Q4
$1.04M Buy
36,790
+5,982
+19% +$171K 0.18% 198
2022
Q3
$926K Buy
30,808
+2,382
+8% +$83K 0.17% 220
2022
Q2
$965K Buy
+28,426
New +$1.02M 0.17% 243

Other funds holding IRMD

Cornercap Investment Counsel's IRMD Position: Q1 2024 in Review

Cornercap Investment Counsel sold out of iRadimed (IRMD) in Q1 2024, closing a stake of 24,396 shares — an estimated $1.16M sold.

Cornercap Investment Counsel first reported a position in IRMD in Q2 2022 and held it in 7 quarters. The position peaked at $1.46M in Q1 2023. 126 funds tracked by Wall St. Rank hold IRMD as of Q1 2024.

  • Cornercap Investment Counsel reported no remaining iRadimed position as of Q1 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 24,396 iRadimed shares in Q1 2024, an estimated $1.16M.
  • Cornercap Investment Counsel first reported a position in iRadimed in Q2 2022 and held it in 7 quarters.
  • Cornercap Investment Counsel's iRadimed position peaked at $1.46M in Q1 2023.
  • 126 funds tracked by Wall St. Rank held iRadimed as of Q1 2024.

Based on Cornercap Investment Counsel's 13F filing for Q1 2024, filed 10 May 2024.